MR1 and neoplasm: MAIT cells exist widely in various TMEs and can be activated by the MR1 of tumor cells via IL-17, thereby inhibiting the effector functions of NK cells and/or CD8+ T cells (including IFN-γ release and degranulation) to promote tumor initiation, proliferation, and metastasis [80, 81].